BioAmass Summit

BioAmass Summit
date
October 1, 2026
TIme
9:30 - 16:00 BST
Address

BioCity Nottingham - Pioneer Group, Pennyfoot Street, Nottingham, NG1 1GF

Strengthening the East Midlands’ life sciences and biotech ecosystem: Working together to accelerate innovation, growth and impact

The Government now explicitly recognises the East Midlands as a strategic innovation region with strengths in life sciences, health technology, advanced manufacturing and engineering biology, but the region still lacks the visibility and coordination enjoyed by some of the UK's better-known clusters.

This one-day BioAmass event is a discussion as to how, as those actively involved in life sciences and biotechnology within the East Midlands, we can come together to coordinate and capitalise on our strengths, to build a productive, competitive and recognised innovation cluster in our region that can accelerate regional growth.

Open to biotech and life sciences company leaders, founders, investors, academia including students, government and the wider innovation ecosystem, we’ll explore why the East Midlands has been highlighted and, more importantly, what practically we need to do to create a sustainable platform from which to grow exciting new ideas into exciting new internationally impactful but regionally located businesses, not only in life sciences and biotechnology/engineering biology, but also in the closely related areas of medtech and clean technologies.

In terms of the day itself, the morning will be dedicated to two panels - “Why Nottingham?” and “How do we make it happen?” - involving a broad range of innovation specialists ready to share their own specific perspectives before a ‘Lightening Showcase’ promoting some of the innovators and organisations shaping the future of the East Midlands.

During the afternoon we have a packed programme of entertaining activities specifically designed - just like our regular BioAmass get togethers - to spark ideas, start new conversations and help people get to know each other.

Omnia v Sidel: UPC opens the door to pre-patent grant actions

Omnia v Sidel: UPC opens the door to pre-patent grant actions

Potter Clarkson launches dedicated women’s health & femtech team

Potter Clarkson launches dedicated women’s health & femtech team

Drug discovery in space: How microgravity is transforming pharmaceutical innovation

Drug discovery in space: How microgravity is transforming pharmaceutical innovation

EU design law gets a digital upgrade

EU design law gets a digital upgrade

EU AI Act Article 50: New AI transparency rules

EU AI Act Article 50: New AI transparency rules

Priority patent applications for biotech and chemistry startups

Priority patent applications for biotech and chemistry startups

The deal killers investors often find too late: An IP lawyer’s guide to investor readiness

The deal killers investors often find too late: An IP lawyer’s guide to investor readiness

Potter Clarkson experts recognised in Lexology Index 2026

Potter Clarkson experts recognised in Lexology Index 2026

See All News